SFM
RPTX

Sphera Funds Management’s Repare Therapeutics RPTX Stock Holding History

Sphera Funds Management’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100,391
Closed -$2.63M – 120
2021
Q3 		$2.63M Hold
100,391
– – 0.22% 90
2021
Q2 		$3.13M Sell
100,391
-147,709
-60% -$4.84M 0.21% 89
2021
Q1 		$7.61M Buy
248,100
+23,800
+11% +$808K 0.58% 45
2020
Q4 		$7.69M Sell
224,300
-20,700
-8% -$618K 0.68% 48
2020
Q3 		$7.54M Hold
245,000
– – 0.74% 38
2020
Q2 		$7.6M Buy
+245,000
New +$7.86M 0.71% 37

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Sphera Funds Management's RPTX Position: Q4 2021 in Review

Sphera Funds Management sold out of Repare Therapeutics (RPTX) in Q4 2021, closing a stake of 100,391 shares — an estimated $2.63M sold.

Sphera Funds Management first reported a position in RPTX in Q2 2020 and held it in 6 quarters. The position peaked at $7.69M in Q4 2020. 67 funds tracked by Wall St. Rank hold RPTX as of Q4 2021.

  • Sphera Funds Management reported no remaining Repare Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Sphera Funds Management sold 100,391 Repare Therapeutics shares in Q4 2021, an estimated $2.63M.
  • Sphera Funds Management first reported a position in Repare Therapeutics in Q2 2020 and held it in 6 quarters.
  • Sphera Funds Management's Repare Therapeutics position peaked at $7.69M in Q4 2020.
  • 67 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2021.

Based on Sphera Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.